Martin Čemerin

Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment

D. Primorac, L. Girandon, S. Minger, 2021, Pharmaceutics.

Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review

D. Primorac, V. Molnar, C. Tremolada, 2022, Genes.

Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study

D. Primorac, V. Molnar, D. Erceg, 2022, Croatian medical journal.

Polychromatic Flow Cytometric Analysis of Stromal Vascular Fraction from Lipoaspirate and Microfragmented Counterparts Reveals Sex-Related Immunophenotype Differences

D. Primorac, G. Lauc, I. Borić, 2021, Genes.

Medicinal signaling cells niche in stromal vascular fraction from lipoaspirate and microfragmented counterpart

D. Primorac, G. Lauc, I. Borić, 2022, Croatian medical journal.

Results of Treating Mild to Moderate Knee Osteoarthritis with Autologous Conditioned Adipose Tissue and Leukocyte-Poor Platelet-Rich Plasma

D. Primorac, I. Borić, V. Molnar, 2022, Journal of personalized medicine.